ACRS
Aclaris Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$3.48
+6.10%Sep 15, 2026, 13:50 UTC
Aclaris Therapeutics (ACRS) shares surged 6.0% in the latest trading session on above-average volume.
Source:Aug 6, 2026, 00:00 UTC
Aclaris Therapeutics reported its Q2 2026 financial results, with total revenue of $1.6 million and a net loss of $21.5 million.
Source: